Does S2341 require prior authorization?

No, S2341 does not require prior authorization (high confidence). Code is covered without prior authorization.

What is the Medicare reimbursement rate for S2341?

Medicare facility rate: N/A. Non-facility rate: N/A. Work RVU: 0.00.

HCPCS/CPT

No Prior Auth Required

Code is covered without prior authorization (high confidence)

Work RVU

0.00

Facility

N/A

Non-Facility

N/A

For LEMG: documentation of duration of vocal fold paralysis and reason LEMG is being performed — the policy states "if prognostic information is needed in a patient with vocal fold paralysis that is more than 4 weeks and less than 6 months in duration, then LEMG should be performed."
LEMG findings relevant to prognosis/management should be documented (examples cited: "Active voluntary motor unit potential recruitment and presence of poly-phasic motor unit potentials within the first 6 months after lesion onset predicted recovery"; note presence/absence of fibrillation potentials/positive sharp waves and any electrical synkinesis).
Pre- and post-procedure voice assessments and objective voice measures where applicable (examples used across studies include Voice Handicap Index [VHI, VHI-10], Voice-Related Quality of Life [V-RQOL], Voice Outcome Survey [VOS], Voice Handicap Index/Voice-Related Quality of Life scores, GRBAS perceptual scale, maximum phonation time [MPT], acoustic/aerodynamic measures, jitter/shimmer, S:Z ratio).

Botulinum toxin (BTX) injection into laryngeal muscles (e.g., bilateral cricothyroid muscles in reported cases) as a symptomatic treatment to relieve dyspnea/laryngeal dyspnea in selected patients with bilateral vocal fold paralysis or periodic laryngeal dyspnea.
Injections of bulking agents for members with unilateral vocal cord paralysis using agents that are cleared by the Food and Drug Administration for this indication
Medialization thyroplasty (also known as type 1 thyroplasty) for vocal cord paralysis
A Gore Tex/silastic implant is considered medically necessary for this indication
Steroid injection after microsurgical removal of vocal fold lesions for reduction of postoperative inflammation and scar formation
Radiesse (calcium hydroxylapatatite and hyaluronic acid gel) for the treatment of permanent vocal cord paralysis/insufficiency

AETNA-CPB-0253, Vocal Cord Paralysis / Insufficiency Treatments

BCBSIL-RX501.019, Botulinum Toxin

BCBSMT-RX501.019, Botulinum Toxin

BCBSNM-RX501.019, Botulinum Toxin

BCBSOK-RX501.019, Botulinum Toxin

Ask Verity about documentation requirements, denial risks, or coverage in your state.